Marilyn Brachman Hoffman Foundation

The Marilyn Brachman Hoffman Foundation is a private nonprofit organization based in Fort Worth, Texas, established in 1999. The foundation is dedicated to advancing research and advocacy for individuals suffering from multiple chemical sensitivities (MCS), a condition that affects how the body responds to various environmental chemicals.

Mission and Objectives

The foundation's mission is to promote education and research related to the health impacts of chemical exposures. It aims to improve the lives of those affected by MCS through funding innovative research projects and supporting programs that increase awareness and understanding of this condition. Notably, the foundation has played a significant role in funding initiatives that examine the physiological mechanisms of chemical sensitivities.

History

The foundation was established in memory of Marilyn Brachman Hoffman (1930-2013), who lived with MCS for over fifty years. Her experiences highlighted the challenges faced by those with chemical sensitivities, and her legacy continues to influence research and advocacy in this area. Following her passing, the foundation was endowed with a significant bequest directed to the Harvard T.H. Chan School of Public Health, leading to the creation of the Marilyn Brachman Hoffman Program for Chemicals and Health. This program seeks to explore the connections between chemical exposures and health outcomes, thus furthering the foundation's mission.

Financial Information

The foundation operates under the Employer Identification Number 752761459 and has recently reported substantial financial holdings, with total assets amounting to approximately $47.5 million as of 2023. In that fiscal year, the organization reported total revenue of $1.82 million, with total expenses of $2.68 million, primarily directed toward charitable disbursements and operational costs.

Grants and Research Funding

The Marilyn Brachman Hoffman Foundation actively funds various research initiatives aimed at understanding chemical intolerance and its effects on health. Its support has enabled the TILT Research Program, which investigates environmental conditions that exacerbate MCS in affected populations. Through these programs, the foundation seeks to foster scientific advances and provide resources for further study into the biology of chemical sensitivities.

Conclusion

The Marilyn Brachman Hoffman Foundation stands as a critical entity in the realm of health advocacy and research related to chemical sensitivities. Its commitment to supporting innovative research and raising awareness about MCS continues to enhance the understanding of this complex health issue.

[1] https://projects.propublica.org/nonprofits/organizations/752761459 [2] https://hsph.harvard.edu/research/hoffman-program/about-us/marilyn-b-hoffman/ [3] https://tiltresearch.org/about/ [4] https://fconline.foundationcenter.org/fdo-grantmaker-profile/?key=HOFF414 [5] https://www.causeiq.com/organizations/marilyn-brachman-hoffman-foundation,752761459/